Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVOW) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Alvotech (ALVOW) over the last 6 years, with Q3 2025 value amounting to $51.4 million.

  • Alvotech's Cash & Equivalents fell 5651.79% to $51.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.4 million, marking a year-over-year decrease of 5651.79%. This contributed to the annual value of $11.2 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Alvotech reported Cash & Equivalents of $51.4 million as of Q3 2025, which was down 5651.79% from $151.5 million recorded in Q2 2025.
  • Over the past 5 years, Alvotech's Cash & Equivalents peaked at $151.5 million during Q2 2025, and registered a low of $11.2 million during Q3 2023.
  • In the last 5 years, Alvotech's Cash & Equivalents had a median value of $51.4 million in 2024 and averaged $58.4 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 9036.89% in 2024, then surged by 125746.17% in 2025.
  • Over the past 5 years, Alvotech's Cash & Equivalents (Quarter) stood at $17.6 million in 2021, then soared by 278.37% to $66.4 million in 2022, then tumbled by 83.2% to $11.2 million in 2023, then skyrocketed by 360.95% to $51.4 million in 2024, then changed by 0.0% to $51.4 million in 2025.
  • Its Cash & Equivalents was $51.4 million in Q3 2025, compared to $151.5 million in Q2 2025 and $51.4 million in Q1 2025.